Paul E. Sax, MDClinical Director
Jill Crank CRNP, MSN/MPHJohns Hopkins Community Physicians
*Define patient populations at higher risk for antiretroviral weight gain
*Determine optimal initial therapy regimens for patients at high risk for antiretroviral weight gain
*Apply appropriate ART modification strategies for patients experiencing antiretroviral weight gain
An emerging trend with highly effective antiretroviral therapy regimens is a substantial amount of weight gain upon ART initiation or a switch in the regimen. Interestingly, however, this weight gain is not recognized in all patients, and understanding who may be more at risk is important when initiating or switching therapy. Additionally, optimal management strategies are continually evolving based on rapidly accumulating data. Join Paul Sax, MD, and Jill Crank, CRNP, for a practical, case-based discussion on antiretroviral weight gain, including the current thinking on how to best manage this side effect.
The content for this program has been independently developed by Clinical Care Solutions.